Atlas Trials

Lantu Biopharma

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Lantu Biopharma

RecordFirmDate
Real World Clinical Effectiveness & Safety of Vesemnogene Lantuparvovec for Spinal Muscular Atrophy (SMA) in Low-middle Income Countries (LMIC). (NCT07265232)Lantu Biopharma2025-10-15
An Open Label Study of Gene Therapy Product (Vesemnogene Lantuparvovec) in Spinal Muscular Atrophy (NCT06288230)Lantu Biopharma2024-10-20
An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia (NCT06308159)Lantu Biopharma2024-05-11

Track Lantu Biopharma automatically

Every clearance here is in the API, with alerts when new ones post.